129 related articles for article (PubMed ID: 36730555)
1. LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.
Du Q; Huang L; Guo W
Anticancer Drugs; 2023 Jul; 34(6):735-746. PubMed ID: 36730555
[TBL] [Abstract][Full Text] [Related]
2. lncRNA ARAP1-AS1 enhances proliferation and impairs apoptosis of lymphoma cells by sponging miR-6867-5p.
Pang B; Gan Y; Wang J; Qu S
Cancer Biomark; 2023; 38(3):333-342. PubMed ID: 37599524
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis.
Zhang W; Zhang J; Hu Z; Sun W; Xu L; Chu H; Wang X; Fu Q
Mol Biotechnol; 2022 Nov; 64(11):1259-1269. PubMed ID: 35556220
[TBL] [Abstract][Full Text] [Related]
4. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5.
Wu Z; Zeng X; Wang H; Wang X
Cancer Biomark; 2023; 38(2):177-189. PubMed ID: 37545214
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2.
Zhou L; Xu XL
Pathobiology; 2021; 88(4):301-312. PubMed ID: 33965958
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
Liu J; Pan C; Lu R; Zhang S
Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
[TBL] [Abstract][Full Text] [Related]
14. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
Huang T; Guan S; Wang C
Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
[TBL] [Abstract][Full Text] [Related]
15. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis.
Dong B; Zhang F; Zhang W; Gao Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
Lu C; Wang X; Zhao X; Xin Y; Liu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
Yi D; Zhang D; He J
Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
[TBL] [Abstract][Full Text] [Related]
19. IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH.
Zhou Y; Liu S; Luo Y; Zhang M; Jiang X; Xiong Y
Eur J Histochem; 2020 Dec; 64(4):. PubMed ID: 33272009
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
